The strategic approach of ABcann’s growth technique
In this interview, Aaron Keay, CEO of ABcann Global Corporation, speaks with Natasha Frakes about why the company waited two years from getting their license before going public, the factors that differentiate the company from competitors, as well as their strategy in the Canadian marketplace. Aaron discusses how the company manages the health of its plants in order to ensure that deviation and variance in the product is minimal. He goes on to explain how the company’s path to success in Canada is based on a scaling method, which allows the company to grow one premium product with an increased production capacity.
Learn more about ABcann Global Corporation on their website: http://www.abcannglobal.com
If you want to learn more about the Market One Minute and how your company can reach millions of investors on BNN, please visit the Market One Minute section of our website here: http://bit.ly/2qGGbkd
Missed an episode of a Market One Minute segment? Here’s a playlist to catch up on any you’ve missed: http://bit.ly/2s64IC0